1. 502PEpidermal growth factor receptor tyrosine kinase inhibitor treatment response in advanced non-small cell lung cancer with uncommon mutations: A multicenter observational study. (24th November 2019) Authors: Kanazu, M; Mori, M; Shiroyama, T; Nagatomo, I; Ihara, S; Komuta, K; Suzuki, H; Hirashima, T; Kimura, M; Imamura, F Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 516PClinical outcomes in elderly patients with advanced non-small cell lung cancer: A prospective multicenter study of the National Hospital Organization in Japan. (24th November 2019) Authors: Shimada, M; Kanazu, M; Shimokawa, M; Saito, R; Mori, M; Tamura, A; Okano, Y; Fujita, Y; Endo, T; Motegi, M; Takata, S; Kita, T; Sukoh, N; Takenoyama, M; Atagi, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 540PClinical outcomes in non–small cell lung cancer patients with ultra-high expression of programmed death ligand-1 treated with pembrolizumab as first-line therapy: A retrospective multicenter cohort study. (25th November 2018) Authors: Kurebe, H; Edahiro, R; Kanazu, M; Fujimoto, D; Tamiya, M; Tamiya, A; Suzuki, H; Hirano, K; Yokoyama, T; Morita, M; Fukuda, Y; Uchida, J; Makio, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗